Redmile Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.16M | Sell |
85,301
-107,982
| -56% | -$11.6M | 0.98% | 24 |
|
2025
Q1 | $19.5M | Sell |
193,283
-119,400
| -38% | -$12M | 1.84% | 17 |
|
2024
Q4 | $27.9M | Sell |
312,683
-18,190
| -5% | -$1.62M | 1.95% | 19 |
|
2024
Q3 | $27.7M | Sell |
330,873
-59,380
| -15% | -$4.98M | 1.63% | 27 |
|
2024
Q2 | $30.1M | Sell |
390,253
-170,673
| -30% | -$13.1M | 1.82% | 23 |
|
2024
Q1 | $38.4M | Sell |
560,926
-132,274
| -19% | -$9.06M | 1.41% | 27 |
|
2023
Q4 | $40.1M | Sell |
693,200
-81,000
| -10% | -$4.68M | 1.43% | 20 |
|
2023
Q3 | $40.9M | Buy |
774,200
+383,022
| +98% | +$20.2M | 1.94% | 14 |
|
2023
Q2 | $21.2M | Buy |
391,178
+219,398
| +128% | +$11.9M | 0.81% | 36 |
|
2023
Q1 | $8.59M | Buy |
+171,780
| New | +$8.59M | 0.37% | 54 |
|
2020
Q4 | – | Sell |
-1,422,049
| Closed | -$54.3M | – | 88 |
|
2020
Q3 | $54.3M | Buy |
1,422,049
+524,694
| +58% | +$20M | 1% | 35 |
|
2020
Q2 | $31.5M | Buy |
+897,355
| New | +$31.5M | 0.58% | 45 |
|
2020
Q1 | – | Sell |
-1,631,200
| Closed | -$73.8M | – | 71 |
|
2019
Q4 | $73.8M | Buy |
+1,631,200
| New | +$73.8M | 1.76% | 20 |
|
2017
Q4 | – | Sell |
-603,493
| Closed | -$17.6M | – | 73 |
|
2017
Q3 | $17.6M | Sell |
603,493
-491,490
| -45% | -$14.3M | 0.87% | 35 |
|
2017
Q2 | $30.4M | Sell |
1,094,983
-105,116
| -9% | -$2.91M | 1.85% | 20 |
|
2017
Q1 | $29.8M | Buy |
1,200,099
+740,594
| +161% | +$18.4M | 1.94% | 18 |
|
2016
Q4 | $9.94M | Sell |
459,505
-613,133
| -57% | -$13.3M | 0.86% | 31 |
|
2016
Q3 | $25.5M | Sell |
1,072,638
-157,682
| -13% | -$3.75M | 2.03% | 17 |
|
2016
Q2 | $28.8M | Sell |
1,230,320
-102,200
| -8% | -$2.39M | 2.75% | 13 |
|
2016
Q1 | $25.1M | Sell |
1,332,520
-918,500
| -41% | -$17.3M | 2.57% | 15 |
|
2015
Q4 | $41.5M | Buy |
+2,251,020
| New | +$41.5M | 3.11% | 13 |
|
2014
Q3 | – | Sell |
-10,000
| Closed | -$128K | – | 55 |
|
2014
Q2 | $128K | Buy |
+10,000
| New | +$128K | 0.02% | 45 |
|